Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 11 Projects
Project # Contact PI Funding Organization Fiscal Year
A Placebo Controlled, Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Mild Cognitive Impairment Due to Alzheimer's disease, nested within a Multi-Arm Phase 2 Clinical Trial Platform
ADDF-13 Ballard, Clive Alzheimer's Drug Discovery Foundation 2020
Evaluating the effects of the novel GLP-I analogue, liraglutide, in patients with Alzherimer's disease (ELAD Study) - Open Label Extension
GC-2013910 Edison, Paul Alzheimer's Drug Discovery Foundation 2017
CHEVAL-in: neurophysiological determinants of conversion to psychosis and response to cholinesterase inhibitors in Parkinson's disease
EUJPND-ParkVern-Foncke-1737 Foncke, E.M.J. Parkinson Vereniging 2016
Improving cognitive functioning in Parkinson's Disease with transcranial Direct Current Stimulation.
EUJPND-ParkVern-Klein-1739 Klein, M. Parkinson Vereniging 2016
Online cognitieve training bij de ziekte van Parkinson. Online cognitive training in Parkinson's disease
EUJPND-ParkVern-van den Heuvel-1742 van den Heuvel, O.A. Parkinson Vereniging 2016
Etanercept in Alzheimer's Disease: a randomised, placebo controlled, double-blind phase 2 trial
GH-2012563 HOLMES, CLIVE Alzheimer's Drug Discovery Foundation 2015
Repurposing the PDE5 inhibitor tadalafil for vascular cognitive impairment. A test of concept in older people
20140901-Hainsworth-2014 Hainsworth, Atticus Alzheimer's Drug Discovery Foundation 2014
Novel GLP-1 and GIP dual receptor agonist peptides show neuroprotective effects
222-Holscher-2014 Holscher, Christian Alzheimer's Drug Discovery Foundation 2014
Repurposed drugs targeting the unfolded protein response to prevent neurodegeneration in dementia
223-Mallucci-2014 Mallucci, Giovanna Alzheimer's Drug Discovery Foundation 2014
Effect of Novel GLP1 analogue, Liraglutide on microglial activation and cerebral glucose metabolism in mild Alzheimer's disease.
20111202-Edison-2011 Edison, Paul Alzheimer's Drug Discovery Foundation 2011